U.S. markets closed

S&P 500
3,841.94
+73.47(+1.95%)
Dow 30
31,496.30
+572.16(+1.85%)
Nasdaq
12,920.15
+196.68(+1.55%)

Sanofi (SNYNF)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

91.40+2.65 (+2.99%)

At close: 12:27PM EST

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	88.75
Open	91.35
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	91.35 - 91.40
52 Week Range	77.00 - 108.61
Volume	449
Avg. Volume	4,673

Market Cap	115.653B
Beta (5Y Monthly)	0.35
PE Ratio (TTM)	23.56
EPS (TTM)	3.88
Earnings Date	N/A
Forward Dividend & Yield	3.41 (3.74%)
Ex-Dividend Date	May 04, 2020
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

Research Reports

Yahoo Finance Video
Money worries are holding people back from getting the vaccine
Yahoo Finance’s Adriana Belmonte and Kristin Myers discuss findings from the KFF COVID-19 Vaccine Monitor.
- Young People May Have More Side Effects From the COVID Vaccine - Doctors Explain Why
  POPSUGAR
- Who’s next in line for the COVID-19 vaccine in Texas? Answer expected in coming days
  Fort Worth Star-Telegram
Yahoo Finance Video
Doctor: ‘We may be reaching that critical point of herd immunity’
Dr. Marcos Sanchez-Gonzalez, Larkin Health System VP for Research & Academic Affairs, joins Yahoo Finance’s Kristin Myers to discuss the latest coronavirus updates.
- Q&A: Dr. Allison Arwady Addresses COVID-19 Vaccine Timeline, Brazilian Variant Identification In Chicago
  CBS Chicago - WBBM TV
- U.S. embraces COVID-19 vaccines, improving odds of herd immunity
  LA Times
Zacks
Sanofi's (SNY) Dupixent sBLA for Asthma Gets FDA Acceptance
The FDA accepts Sanofi's (SNY) sBLA for review of Dupixent for treating moderate-to-severe asthma in children aged six-11 years. A verdict from the FDA is expected on Oct 21, 2021.